Séminaire BioCIS : "XCE853 : Inhibitor of Protein disulfide Isomerase against cancer"
Dr Grégoire Prevost (CIPREVO, Antony)
Jeudi 30 janvier 2020, 10h30Passé
Séminaire BioCIS : "XCE853 : Inhibitor of Protein disulfide Isomerase against cancer"
Dr Grégoire Prevost (CIPREVO, Antony)
Université Paris-Sud - Faculté de Pharmacie - Salle des thèses
CIPREVO is a new service company providing expertise on cancer research and development projects to clients such Pharmas, Biotechs, Start-ups,Consortiums, Investors, Funds, Academic groups or Patient associations.
https://www.ciprevo-cancer.com/
Chimie
